Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT03941951
Eligibility Criteria:
Pre-intervention cohort (historical):
Inclusion criteria:
* All patients treated with ceftaroline, tedizolid, dalbavancin, ceftazidime-avibactam, ceftolozane-tazobactam or isavuconazole.
* In a hospital or ambulatory regime.
* That they have received at least 1 dose of treatment of any of the antimicrobials mentioned, either as empirical or directed treatment.
* Adults (18 years).
* Between January 1, 2016 and December 31, 2019.
Exclusion criteria:
• There are no exclusion criteria except for age.
Intervention cohort:
Inclusion criteria:
* All patients treated with ceftaroline, tedizolid, dalbavancin, ceftazidime-avibactam, ceftolozane-tazobactam or isavuconazole.
* In a hospital or ambulatory regime.
* That they have received at least 1 dose of treatment of any of the antimicrobials mentioned, either as empirical or directed treatment.
* Adults (18 years).
* From January 1, 2020 to December 31, 2021.
* Since the publication and diffusion of the recommendation guide.
Exclusion criteria:
• There are no exclusion criteria except for age.
Safety cohort:
Inclusion criteria:
* All episodes of clinically significant bacteremia (that have received any treatment) produced by:
* Acinetobacter baumannii resistant or with intermediate susceptibility to any carbapenem.
* Pseudomonas aeruginosa resistant or with intermediate susceptibility to any carbapenem.
* Enterobacteria resistant or with intermediate susceptibility to any carbapenem.
* Vancomycin-resistant Enterococcus faecium.
* Methicillin-resistant Staphylococcus aureus.
* From January 1, 2017 to December 31, 2021.
* Adult patients (18 years old).
Exclusion criteria:
• There are no exclusion criteria except for age.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03941951
Study Brief:
Protocol Section:
NCT03941951